Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2021. Read More.
Open Access Percentage
45%
Total
Publications
1.2K
Total Open
Publications
562
Total
Citations
80K
Open Access
Percentage
45%
Total
Publications
1.2K
Total Open
Publications
562
Total
Citations
80K
Breakdown
Publisher Open
13%
Both
18%
Other Platform Open
14%
Closed
55%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
112
Hybrid 45%
176
No Guarantees 26%
102
Other Platform Open
Domain 86%
345
Institution 33%
134
Public 7%
29
Preprint 6%
26
Other Internet 5%
20
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | 346 | |
Europe PMC | 281 | |
Semantic Scholar | 26 | |
Imperial College London - Spiral | 22 | |
University of Oxford - Oxford University Research Archive (ORA) | 14 | |
University of North Carolina at Chapel Hill - Carolina Digital Repository | 13 | |
bioRxiv | 13 | |
University of Cambridge - Apollo | 12 | |
DOI | 12 | |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | 11 |